Steven R. Pacelli - Mar 8, 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP Managing Director Dexcom V
Signature
By: Jereme Sylvain For: Steven R Pacelli
Stock symbol
DXCM
Transactions as of
Mar 8, 2023
Transactions value $
$19
Form type
4
Date filed
3/10/2023, 02:58 PM
Previous filing
Feb 23, 2023
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $18.80 +18.8K +13.76% $0.00* 155K Mar 8, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
F2 Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.